Role of Parental Smoking in Severe Bronchiolitis: A Hospital Based Case-Control Study

Rubina Farzana1, Mujibul Hoque2, Mohammad Shah Kamal3

  • 1Leprosy Hospital, Sylhet, Bangladesh.

Insights

Parental smoking significantly increases the risk of severe bronchiolitis in infants. This study found children exposed to parental smoke were 2.8 times more likely to develop severe bronchiolitis.

Area of Science:

  • Pediatrics
  • Environmental Health
  • Epidemiology

Background:

  • Bronchiolitis is a leading cause of infant hospitalization in Bangladesh, affecting approximately 21% of children under five.
  • Parental smoking is a known risk factor for bronchiolitis susceptibility and severity.
  • Bangladesh has a high prevalence of smoking, with 50% of men and 3% of women being smokers.

Purpose of the Study:

  • To investigate the association between parental smoking and the risk of severe bronchiolitis in infants.
  • To quantify the increased risk of severe bronchiolitis due to parental smoking exposure.

Main Methods:

  • A case-control study was conducted with 64 infants diagnosed with severe bronchiolitis (cases) and 64 healthy matched controls.
  • Data were collected from July 2013 to December 2015 at Sylhet MAG Osmani Medical College Hospital, Bangladesh.
  • Systematic random sampling was employed to select participants.

Main Results:

  • Children with severe bronchiolitis were more likely to have been exposed to parental smoking (59% of cases vs. 34% of controls).
  • Parental smoking exposure was statistically significant (p = 0.005) and associated with an odds ratio of 2.8 (95% CI: 1.36-5.72).
  • The average age of patients was 7.53 months, with a male-to-female ratio of 1.7:1.

Conclusions:

  • Exposure to parental smoking significantly increases the risk of developing severe bronchiolitis in infants.
  • The findings highlight the critical role of parental smoking as a modifiable risk factor for severe infant respiratory illness.
  • Public health initiatives should focus on parental smoking cessation to reduce the burden of bronchiolitis.

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...